Dream Tech has been spun out to develop a better method for conducting risk assessments on food, pharmaceuticals and pesticides.
Indiana University disclosed the launch of a US-based biotech spinout called Dream Tech on Monday, formed to commercialise a more dependable system for conducting regulatory risk assessments.
The research uses a Bayes estimator, a probabilistic concept that can compensate for the lack of demonstrative evidence when making predictions, in a bid to tighten the assessment of chemical toxicity.
Dream Tech hopes the technology will aid federal and international regulators scrutinising the safety of chemicals in food, pharmaceuticals and pesticides.
The…
